Literature DB >> 22309324

The use of methotrexate in dermatology: a review.

Sarah Shen1, Tim O'Brien, Lei Mee Yap, H Miles Prince, Christopher J McCormack.   

Abstract

Methotrexate is a synthetic folic acid analogue valued for both its anti-proliferative and anti-inflammatory properties. Considered one of the original immune-modifying agents, it is used widely for the treatment of steroid-recalcitrant inflammatory diseases. While there are abundant studies documenting its efficacy in rheumatic diseases, the use of methotrexate for dermatological conditions, with the exception of psoriasis, has yet to be comprehensively explored. This two-part review firstly outlines current data concerning the pharmacology of methotrexate, including its mechanism of action, side-effect profile and recommended therapeutic approach, and, secondly, examines the emerging evidence for methotrexate's efficacy in a wide range of cutaneous disorders.
© 2011 The Authors. Australasian Journal of Dermatology © 2011 The Australasian College of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22309324     DOI: 10.1111/j.1440-0960.2011.00839.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  22 in total

1.  An unusual case of acute methotrexate toxicity manifesting as ulcers on psoriatic plaques in an elderly male.

Authors:  G K Singh; Manas Chatterjee; Santanu Banerjee; Sourabh Kumar
Journal:  Med J Armed Forces India       Date:  2013-02-23

2.  [Current status of oral immunomodulatory and immunosuppressive agents].

Authors:  S Meller; A M Baran; S A Braun; N Klossowski; B Homey
Journal:  Hautarzt       Date:  2014-02       Impact factor: 0.751

Review 3.  Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome.

Authors:  Louise Photiou; Carrie van der Weyden; Christopher McCormack; H Miles Prince
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

4.  Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid-A Single Center Retrospective Analysis.

Authors:  Agoritsa Gravani; Georgios Gaitanis; Panagiota Spyridonos; Ioannis Alexis; Stelios Tigas; Ioannis D Bassukas
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

5.  Systemic methotrexate for prurigo nodularis and keratoacanthomas in actinically damaged skin.

Authors:  Amy Kalowitz Bieber; David E Cohen; Jennifer A Stein
Journal:  JAAD Case Rep       Date:  2016-07-14

Review 6.  Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.

Authors:  Ana M Martins; Andreia Ascenso; Helena Margarida Ribeiro; Joana Marto
Journal:  Mol Neurobiol       Date:  2020-02-15       Impact factor: 5.590

7.  Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma.

Authors:  Christina E Wells; Srividya Bhaskara; Kristy R Stengel; Yue Zhao; Bianca Sirbu; Benjamin Chagot; David Cortez; Dineo Khabele; Walter J Chazin; Andrew Cooper; Vincent Jacques; James Rusche; Christine M Eischen; Laura Y McGirt; Scott W Hiebert
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

Review 8.  A marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate.

Authors:  Hartmut Glossmann; Norbert Reider
Journal:  Dermatoendocrinol       Date:  2013-04-01

9.  Effect of Narrow-Band Ultraviolet B Phototherapy and Methotrexate on MicroRNA (146a) Levels in Blood of Psoriatic Patients.

Authors:  Asmaa M Ele-Refaei; Fatma M El-Esawy
Journal:  Dermatol Res Pract       Date:  2015-10-29

10.  Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.

Authors:  Anja Weidmann; Amy C Foulkes; N Kirkham; N J Reynolds
Journal:  Dermatol Ther (Heidelb)       Date:  2014-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.